EXACT Therapeutics AS – Primary Insider Notice
EXACT Therapeutics AS (EXTX) · publisert 9. juni 2022 kl. 06:41 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass |
|---|---|---|---|---|---|---|---|
| Anders Wold | – | Kjøp Emisjon/tegning | 2 414 | 19 NOK | 8. juni 2022 | – | MERK Oslo Børs |
Vedlegg
- Notification of Trade - Primary Insider Anders Wold June 2022.pdf (application/pdf, originaldokument)
Meldingstekst
OSLO/LONDON, 9 June 2022: Reference is made to the stock exchange release by EXACT Therapeutics AS (“EXACT-Tx”, “the Company” Euronext Growth: EXTX) on 9 June 2022 regarding a share capital increase in connection with the Company's restricted stock unit (RSU) programme.
Anders Wold, Chair of EXACT-Tx, has subscribed for 2,414 shares at NOK 19.00 per share. Following this transaction, Anders Wold will hold 2,414 shares in EXACT-Tx. Attached is the notification of trade of primary insider.